GLP-1 for PCOS: Semaglutide, Tirzepatide, and Retatrutide

Polycystic Ovary Syndrome (PCOS) affects millions of women and often shows up as stubborn weight changes, insulin resistance, intense cravings, fatigue, and difficulty maintaining metabolic balance. For many women with PCOS, traditional diet and exercise approaches feel like pushing against a wall — because the underlying biology is working against them.

Why PCOS Makes Weight Loss Harder

PCOS is fundamentally a hormonal and metabolic condition. The most common drivers include:

• • Insulin resistance — cells don't respond normally to insulin, leading to higher insulin levels that promote fat storage
• • Elevated androgens — higher testosterone levels that contribute to weight gain, particularly around the abdomen
• • Hormonal imbalances — disrupted LH/FSH ratios that affect metabolism and appetite regulation
• • Chronic low-grade inflammation — which can worsen insulin resistance and metabolic function

How GLP-1 Medications Help with PCOS

GLP-1 receptor agonists work on multiple pathways that are directly relevant to PCOS:

• • Improve insulin sensitivity — directly addressing one of the core drivers of PCOS
• • Reduce appetite and cravings — helping break the cycle of carbohydrate cravings common in PCOS
• • Support weight loss — which itself improves hormonal balance and reduces androgen levels
• • Reduce inflammation — GLP-1 medications have anti-inflammatory properties that benefit metabolic health

Semaglutide, Tirzepatide, and Retatrutide for PCOS

Semaglutide ($499/month)

A GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and improves blood sugar regulation. Well-studied for weight loss and metabolic improvement — a strong starting point for many women with PCOS.

Tirzepatide ($599/month)

A dual GIP/GLP-1 receptor agonist that targets two hormonal pathways simultaneously. The dual mechanism may offer additional benefits for insulin resistance — a key driver in PCOS — with superior weight loss results compared to semaglutide alone.

Retatrutide ($699/month)

The newest generation — a triple agonist (GLP-1, GIP, and glucagon) that activates three metabolic pathways simultaneously. For women with PCOS who have struggled with other approaches, Retatrutide offers the most comprehensive metabolic support currently available.

The Lean Lab Approach to PCOS

At Lean Lab, we don't just prescribe a GLP-1 and send you home. We start with comprehensive labs (including hormones, insulin, thyroid, and metabolic markers), a Styku 3D body composition scan, and a personalized treatment plan that may combine GLP-1 therapy with hormone optimization, IV therapy, and nutritional guidance. Monthly monitoring ensures your plan adapts to your body's response.